A case of diffuse large B-cell lymphoma with interstitial pneumonia

Cancer Pathog Ther. 2023 Jun 19;1(3):220-223. doi: 10.1016/j.cpt.2023.06.001. eCollection 2023 Jul.

Abstract

This report involves a 54-year-old female patient diagnosed with diffuse large B-cell lymphoma who developed interstitial pneumonia (IP) during treatment. The patient presented to the ward with enlarged lymph nodes in the neck and was treated with the standard regimen, which included rituximab, cyclophosphamide, doxorubicin liposomes, vincristine, and prednisone (R-CDOP regimen). After 3 cycles, the treatment was assessed as effective. However, following the 4th cycle, the patient experience shortness of breath after physical activity. A repeat lung computer tomography indicated IP, which completely recovered after receiving "full coverage" treatment. Subsequently, the patient underwent 2 cycles of cyclophosphamide, doxorubicin liposomes, vincristine, and prednisone (CDOP), followed by local radiotherapy. Currently, the patient is now being followed up with regular reviews.

Keywords: Diffuse large B-cell lymphoma; Doxorubicin liposomes; Interstitial pneumonia; Rituximab.

Publication types

  • Case Reports